Skip to main content

Table 1 Basic characteristics of the study participants

From: Vitamin D receptor gene polymorphisms affecting changes in visceral fat, waist circumference and lipid profile in breast cancer survivors supplemented with vitamin D3

Characteristics

Total

Age

50(43–55)

Current smoking, N (%)

1(1)

Hormone receptor status, N (%)

 ER+

89(60)

 ER + PR+

83(56)

 ER + PR-

5(3)

 ER-PR-

35(23)

 HER2+

12(8)

 ER-PR-HER2-

18(12)

Family history of breast cancer, N (%)

25(17)

Post-menopausal, N (%)

111(76)

Hormone therapy for breast cancer

112(76)

Stage, N (%)

 Stage I

33(22)

 Stage II

61(41)

 Stage III

35(24)

 Missing

18(13)

Recurrence N (%)

 Yes

5(3)

 No

77(67)

 Unknown

65(30)

Physical activity levels, N (%)

 Low physical activity

80(54)

 Moderate physical activity

44(30)

 High physical activity

23(16)

Energy intake, Kcal

1901(1832–2046)

Fat intake, grams

84 ± 16

Protein intake, grams

56(49–62)

Carbohydrate intake, grams

243 ± 41

Pre intervention Vitamin D, nmol/liter

38(22–62)

Post intervention vitamin D, nmol/liter

110 ± 46

ApaI N (%)

 AA

68(49)

 Aa

52(38)

 aa

18(13)

TaqI N (%)

 TT

57(41)

 Tt

67(49)

 tt

14(10)

BsmI N (%)

 BB

66(45)

 Bb

65(44)

 bb

16(11)

FokI N (%)

 FF

64(44)

 Ff

66(45)

 ff

17(12)

Cdx2 N (%)

 GG

81(55)

 AG

52(35)

 AA

14(10)

  1. ER Estrogen Receptor, PR Progesterone Receptor, HER2 Human Epidermal Growth Factor Receptor 2, BMI Body Mass Index, BMI Body Mass Index, WC Waist Circumference, HC Hip Circumference
  2. Values with normal distribution are presented as mean ± SD, values with non-normal distribution as median (Q1, Q3) and categorical variables as N (%)